2022 Webinar: Going Beyond the Statement: Improving Diversity, Equity and Inclusion in Hepatology
Recorded On: 02/23/2022
The purpose of this webinar is to discuss action items for the AASLD and academic institutions. These action items will focus on efforts to improve diversity, equity and inclusion in all aspects of the hepatology continuum, including the hepatology work force as well as racial disparities in hepatology care. The webinar will include a formal 10-minute overview of the concepts of diversity, equity and inclusion and another 10-minute formal presentation on proposed future directions outlined in the white paper. There will then be a 20-minute moderated discussion between panelist discussing perceived and actual barriers to these action items. The webinar will conclude with a 10-minute question and answer portion involving all faculty.
Be sure to check out the additional resources in the Handouts section.
Miguel H. Malespin
Miguel H. Malespin M.D. is a transplant hepatologist at Tampa General Hospital and associate professor for the University of South Florida College of Medicine. He earned his medical degree at Ponce Health Sciences University in Puerto Rico. Dr. Malespin continued his training in internal medicine and gastroenterology at the University of Illinois at Chicago. He then completed a fellowship in transplant hepatology at Loyola University Medical Center. His areas of clinical and research interest include non-alcoholic fatty liver disease, viral hepatitis, and health disparities. He is an active member of the AGA and AASLD serving in multiple roles and committees.
Carla W. Brady
Carla Brady, MD, MHS, FAASLD is an Associate Professor in the Division of Gastroenterology at Duke University Medical Center, having been a faculty member within the division since 2006. She is a transplant hepatologist and has a particular interest in liver disease and liver transplantation from a women's health perspective. Dr. Brady is the author of manuscripts on and has given talks locally, regionally, and nationally on liver disease in pregnancy, pregnancy in transplant patients, liver disease and liver transplantation in menopausal women, and disparities in liver disease care. As an active member of the American Association for the Study of Liver Diseases (AASLD), she has served on its Scientific Program Committee and Nominating Committee. She has also served as chair of the AASLD Program Evaluation Committee and as chair of the AASLD Inclusion and Diversity Committee. Locally, she has served as an elected member of the Executive Committee of the Academic Council of Duke University, a steering committee member for the Duke University Academic Council Diversity Task Force and as a co-chair of its subcommittee on Best Practices in Faculty and Administrative Diversity.
Lauren D. Nephew (Moderator)
Lauren D. Nephew, MD, MA, MSCE is Assistant Professor of Medicine in the Division of Gastroenterology and Hepatology at Indiana University School of Medicine. Her research interests include understanding barriers to liver transplantation for vulnerable populations, disparities in care of patients with hepatocellular carcinoma, and the impact of the social and structural determinants of health on the outcomes of patients with liver disease. Dr. Nephew’s clinical work focuses on both decompensated liver disease patients being evaluated for liver transplantation as well as patients with chronic liver disease. She is the chair of the Intersociety Group on Diversity and the chair of the AASLD Inclusion and Diversity Committee.
Dr. Nephew attended medical school at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She completed residency at Massachusetts General Hospital and Gastroenterology and Liver Transplantation Fellowships at the University of Pennsylvania. While at Case Western Reserve University, Dr. Nephew completed a Masters program in Clinical Bioethics. While at the University of Pennsylvania, Dr. Nephew completed a Masters of Science in Clinical Epidemiology. Dr. Nephew is a health equity champion, wife, and mother of two.
Naudia L. Jonassaint
Naudia L. Jonassaint, MD, MHS currently is an Associate Professor of Medicine and Surgery at the University of Pittsburgh School of Medicine. She is currently serving as the Vice Chair of the Diversity, Equity and Inclusion in the Department of Medicine and the Associate Dean of Clinical Affairs in School of Medicine. Dr. Jonassaint has a specific interest in disparate outcomes in liver disease and is also uniquely interested in diversity and inclusion in academic training.
Dr. Jonassaint is currently serving on the Finance Committee for the American Association for the Study of Liver Diseases (AASLD) as well as serving on the editorial board for Liver Transplantation. Her collaborative research focuses the optimization of care for pre-transplant liver patients including transplant selection in addition to a focus on disparities in liver transplant outcomes. As an active teacher and educator, she has mentored many undergraduate, graduate and medical students as well as junior faculty and staff at the University of Pittsburgh and beyond.
Sonali Paul is a transplant hepatologist and Assistant Professor of Medicine at the University of Chicago. She is also the director of the Metabolic and Fatty Liver clinic. She has an interest in non-alcoholic fatty liver disease, obesity medicine, organ allocation, health disparities, and shared decision making between patients and providers. She received an MD from Tufts University School of Medicine. She completed her internal medicine residency at Massachusetts General Hospital and returned to Tufts for her fellowship training in gastroenterology. She also earned an MS in clinical and translational science from the Sackler School of Graduate Biomedical Sciences at Tufts University. She completed an advanced hepatology fellowship at Massachusetts General Hospital in 2016 and joined the University of Chicago faculty shortly thereafter.
Laurie D. DeLeve
Laurie D. DeLeve, MD, PhD, FAASLD has been on the faculty at the University of Southern California in Los Angeles since 1990 and is Professor of Medicine and Vice Chair for Scientific Affairs in the Department of Medicine at the Keck School of Medicine. She received her MD at the Erasmus University of Rotterdam in the Netherlands and her PhD at the University of Toronto in Canada. She did her training in Internal Medicine at the University of Michigan in Ann Arbor, followed by a fellowship in Gastroenterology/Hepatology at UCLA. Dr. DeLeve is a physician-scientist and is involved in patient care, basic research, and education of medical student, residents, and Fellows.
Dr DeLeve’s NIH-funded research has focused on the biology and pathobiology of liver sinusoidal endothelial cells (LSECs). Early work from her laboratory demonstrated that LSECs were the initial target in sinusoidal obstruction syndrome and these studies provided significant insight into the mechanisms of this syndrome. Subsequent research examined the role of LSECs in other forms of liver injury. Dr DeLeve’s lab demonstrated that LSECs maintain hepatic stellate cell quiescence, that LSEC capillarization prior to fibrosis is permissive for hepatic stellate cell activation and why that is so. In recent years, Dr. DeLeve’s lab was the first to identify resident and bone marrow sinusoidal endothelial cell progenitor cells, so-called bone marrow sprocs. Her laboratory has examined the role of bone marrow sprocs in acute and chronic liver injury.